Document:

Form Notice of Grant-Non-Employee Director for 2011 Equity Incentive Plan

 Exhibit 10.11 
 WHITEGLOVE HEALTH, INC. 
 INDEPENDENT NON-EMPLOYEE DIRECTOR

 STOCK ISSUANCE AGREEMENT 
 AGREEMENT made as of this          day of
                    , 20     by and between WhiteGlove Health, Inc., a Delaware corporation (the
“Company”), and                     , Participant in the Company’s 2011 Equity Incentive Plan
(“Participant”). 
 All capitalized terms in this Agreement shall have the meaning
assigned to them in this Agreement or in the Company’s 2011 Equity Incentive Plan (as may be amended from time to time, the “Plan”). 
  

	1.	 Purchase of Shares. 

A. Grant of Restricted Stock. Subject to the conditions described in this agreement and in the
Company’s 2011 Equity Incentive Plan (the “Plan”), the Company hereby grants to Participant                     
shares of Common Stock (the “Restricted Shares”) pursuant to the provisions of Article V of the Plan. 
 B. Stockholder Rights. Until such time as the Company exercises the Repurchase Right, Participant (or any successor in interest) shall have all stockholder rights (including voting, dividend
and liquidation rights) with respect to the Restricted Shares, subject, however, to the transfer restrictions of Section 3 and 4. 
  

	2.	 Securities Law Compliance. 

 A. Disposition of Restricted Shares. Participant shall make no disposition of the Restricted Shares unless and until there is compliance with all of the following requirements: 

(a) Participant shall have provided the Company with a written summary of the terms and conditions of the
proposed disposition. 
 (b) Participant shall have complied with all requirements of this
Agreement applicable to the disposition of the Restricted Shares. 
 The Company shall not be required
(i) to transfer on its books any Restricted Shares which have been sold or transferred in violation of the provisions of this Agreement or (ii) to treat as the owner of the Restricted Shares, or otherwise to accord voting, dividend or
liquidation rights to, any transferee to whom the Restricted Shares have been transferred in contravention of this Agreement. 

 B. Restrictive Legends. The stock certificates for the
Restricted Shares shall be endorsed with the following restrictive legend: 
 THE SHARES
REPRESENTED BY THIS CERTIFICATE HAVE BEEN ISSUED PURSUANT TO THE TERMS OF THE WHITEGLOVE HEALTH, INC. 2011 EQUITY INCENTIVE PLAN AND MAY NOT BE SOLD, PLEDGED, TRANSFERRED, ASSIGNED OR OTHERWISE ENCUMBERED IN ANY MANNER EXCEPT AS IS SET FORTH IN THE
TERMS OF SUCH AWARD DATED             , 20    . A COPY OF SUCH PLAN IS MAINTAINED AT THE COMPANY’S PRINCIPAL CORPORATE OFFICES. 

 

	3.	 Transfer Restrictions. 

 A. Restriction on Transfer. Participant shall not transfer, assign, encumber or otherwise dispose of any of the Restricted Shares which are subject to the Repurchase Right. 

 

	4.	 Repurchase Right. 

 A. Grant. The Company is hereby granted the right (the “Repurchase Right”), exercisable at any time during the sixty (60)-day period following the date Participant
ceases for any reason to remain in service, to repurchase at the lower of (i) the price per share paid for such Restricted Shares (if any) by the Participant or (ii) the Fair Market Value per share of Common Stock on the date of
Participant’s cessation of service (the “Repurchase Price”) any or all of the Restricted Shares in which Participant is not, at the time of his or her cessation of service, vested in accordance with the provisions of the
Vesting Schedule set forth in Paragraph 4.C or any special vesting acceleration provisions effected by the Plan Administrator (such shares to be hereinafter referred to as the “Unvested Shares”). 

B. Exercise of the Repurchase Right. The Repurchase Right shall be exercisable by written notice delivered
to each owner of the Unvested Shares prior to the expiration of the sixty (60)-day exercise period. The notice shall indicate the number of Unvested Shares to be repurchased, the Repurchase Price to be paid per share and the date on which the
repurchase is to be effected, such date to be not more than thirty (30) days after the date of such notice. The certificates representing the Unvested Shares to be repurchased shall be delivered to the Company on the closing date specified for
the repurchase. Concurrently with the receipt of such stock certificates, the Company shall pay to the owner, in cash or cash equivalents (including the cancellation of any purchase-money indebtedness), an amount equal to the Repurchase Price for
the Unvested Shares which are to be repurchased from the owner. 
 C. Termination of the Repurchase
Right. The Repurchase Right shall terminate with respect to any Unvested Shares for which it is not timely exercised under Paragraph 4.B. In addition, the Repurchase Right shall terminate and cease to be exercisable with respect to any
and all Restricted Shares in which Participant vests in accordance with the following “Vesting Schedule”: 
 Participant shall vest in the Restricted Shares, and the Repurchase Right shall concurrently lapse with respect to those Restricted Shares, in a series of twelve (12) successive equal monthly
installments upon Participant’s completion of each month of service over the one-year period measured from                 ,
20    . 

  
 -2-

 D. Recapitalization. Any new, substituted or additional
securities or other property (including cash paid other than as a regular cash dividend) which is by reason of any Recapitalization distributed with respect to the Restricted Shares shall be immediately subject to the Repurchase Right and any escrow
requirements hereunder, but only to the extent the Restricted Shares are at the time covered by such right or escrow requirements. Appropriate adjustments to reflect such distribution shall be made to the number and/or class of Restricted Shares
subject to this Agreement and to the Repurchase Price per share to be paid upon the exercise of the Repurchase Right in order to reflect the effect of any such Recapitalization upon the Company’s capital structure; provided,
however, that the aggregate Repurchase Price shall remain the same. “Recapitalization” shall mean any of the following transactions affecting the Company’s outstanding Common Stock as a class without the
Company’s receipt of consideration: any stock split, stock dividend, spin-off transaction, extraordinary distribution (whether in cash, securities or other property), recapitalization, combination of shares, exchange of shares or other similar
transaction affecting the Common Stock without the Company’s receipt of consideration. 
 E. Change
of Control. 
 (a) In the event a Change of Control occurs during Participant’s
period of service, the Board shall have the authority in its sole discretion to take any one or more of the following actions with respect to this stock issuance, as more fully set forth in the Plan: accelerate vesting of outstanding shares of
Restricted Stock, cause the acquirer to assume the Plan and exchange this award for an award for the acquirer’s stock and terminate the Plan and all outstanding unvested shares of Restricted Stock as of the date of the Change of Control.

 (b) In the event a Hostile Take-Over occurs during Participant’s period of service,
vesting of Participant’s Restricted Stock, to the extent not otherwise fully vested, shall automatically accelerate so that such Restricted Stock shall, immediately prior to the effective date of the Hostile Take-Over, become fully-vested
shares of Common Stock. 
 (c) In the event of a Change of Control, as more fully set forth in
the Plan, the Board shall have the right to require all, but not less than all, Participants to transfer and deliver to the Company all Awards previously granted to the Participants in exchange for an amount equal to the Cash Value (defined below)
of the Awards. Such right shall be exercised by written notice to all Participants. For purposes of this Paragraph 4.E(c), the “Cash Value” of an Award shall equal the sum of (i) the cash value of all benefits to which
the Participant would be entitled upon settlement or exercise of any Award which is not an Option or Restricted Stock and (ii) (A) in the case of any Award that is an Option, the excess of the FMV Per Share over the option exercise price
or (B) in the case of an Award that is Restricted Stock the FMV Per Share of Restricted Stock, multiplied by the number of shares subject to such Award. 

(d) This Agreement shall not in any way affect the right of the Company to adjust, reclassify, reorganize
or otherwise change its capital or business structure or to merge, consolidate, dissolve, liquidate or sell or transfer all or any part of its business or assets. 

  
 -3-

	5.	 Special Tax Election. 

 A. Section 83(b) Election. Under Code Section 83, the excess of the Fair Market Value of the Restricted Shares on the date any forfeiture restrictions applicable to such shares
lapse over the price paid for those Restricted Shares (if any) will be reportable as ordinary income on the lapse date. For this purpose, the term “forfeiture restrictions” includes the right of the Company to repurchase the Restricted
Shares pursuant to the Repurchase Right. Participant may elect under Code Section 83(b) to be taxed at the time the Restricted Shares are acquired, rather than when and as such Restricted Shares cease to be subject to such forfeiture
restrictions. Such election must be filed with the Internal Revenue Service within thirty (30) days after the date of this Agreement. Even if the Fair Market Value of the Restricted Shares on the date of this Agreement equals the price paid
(and thus no tax is payable), the election must be made to avoid adverse tax consequences in the future. 

THE FORM FOR MAKING THIS ELECTION IS ATTACHED AS EXHIBIT II HERETO. PARTICIPANT UNDERSTANDS THAT FAILURE TO MAKE
THIS FILING WITHIN THE APPLICABLE THIRTY (30)-DAY PERIOD WILL RESULT IN THE RECOGNITION OF ORDINARY INCOME AS THE FORFEITURE RESTRICTIONS LAPSE. 
 B. FILING RESPONSIBILITY. PARTICIPANT ACKNOWLEDGES THAT IT IS PARTICIPANT’S SOLE RESPONSIBILITY, AND NOT THE COMPANY’S, TO FILE A TIMELY ELECTION UNDER CODE SECTION
83(b), EVEN IF PARTICIPANT REQUESTS THE COMPANY OR ITS REPRESENTATIVES TO MAKE THIS FILING ON HIS OR HER BEHALF. 
  

	6.	 General Provisions. 

 A. Assignment. The Company may assign the Repurchase Right to any person or entity selected by the Board, including (without limitation) one or more stockholders of the Company. 

B. At Will Service. Nothing in this Agreement or in the Plan shall confer upon Participant any right to
continue in service for any period of specific duration or interfere with or otherwise restrict in any way the rights of the Company (or any Affiliate employing or retaining Participant) or of Participant, which rights are hereby expressly reserved
by each, to terminate Participant’s service at any time for any reason, with or without cause. 
 C.
Notices. Any notice required to be given under this Agreement shall be in writing and shall be deemed effective upon personal delivery or upon deposit in the U.S. mail, registered or certified, postage prepaid and properly addressed to
the party entitled to such notice at the address indicated below such party’s signature line on this Agreement or at such other address as such party may designate by ten (10) days advance written notice under this paragraph to all other
parties to this Agreement. 
 Participant generally consents to the delivery of any notice
pursuant to the Delaware General Corporation Law (the “DGCL”), as amended or superseded from time to time, by electronic transmission pursuant to Section 232 of the DGCL (“Electronic Notice”) at
the 

  
 -4-

 
electronic mail address or the facsimile number as set forth in the books of the Company. To the extent that any notice given via electronic transmission is returned or undeliverable for any
reason, the foregoing consent shall be deemed to have been revoked until a new or corrected electronic mail address has been provided, and such attempted Electronic Notice shall be ineffective and deemed to not have been given. Participant agrees to
promptly notify the Company of any change in Participant’s electronic mail address, but failure to do so shall not affect the foregoing. 
 D. No Waiver. The failure of the Company in any instance to exercise the Repurchase Right shall not constitute a waiver of any other repurchase rights that may subsequently arise under the
provisions of this Agreement or any other agreement between the Company and Participant. No waiver of any breach or condition of this Agreement shall be deemed to be a waiver of any other or subsequent breach or condition, whether of like or
different nature. 
 E. Cancellation of Shares. If the Company shall make available, at the time
and place and in the amount and form provided in this Agreement, the consideration for the Restricted Shares to be repurchased in accordance with the provisions of this Agreement, then from and after such time, the person from whom such shares are
to be repurchased shall no longer have any rights as a holder of such shares (other than the right to receive payment of such consideration in accordance with this Agreement). Such shares shall be deemed purchased in accordance with the applicable
provisions hereof, and the Company shall be deemed the owner and holder of such shares, whether or not the certificates therefor have been delivered as required by this Agreement. 

 

	7.	 Miscellaneous Provisions. 

 A. Governing Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware without resort to that state’s conflict-of-laws rules.

 B. Participant Undertaking. Participant hereby agrees to take whatever additional action and
execute whatever additional documents the Company may deem necessary or advisable in order to carry out or effect one or more of the obligations or restrictions imposed on either Participant or the Restricted Shares pursuant to the provisions of
this Agreement. 
 C. Agreement is Entire Contract. This Agreement constitutes the entire contract
between the parties hereto with regard to the subject matter hereof. This Agreement is made pursuant to the provisions of the Plan and shall in all respects be construed in conformity with the terms of the Plan. 

D. Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed to be an
original, but all of which together shall constitute one and the same instrument. 
 E. Successors and
Assigns. The provisions of this Agreement shall inure to the benefit of, and be binding upon, the Company and its successors and assigns and upon Participant, Participant’s assigns and the legal representatives, heirs and legatees of
Participant’s estate, whether or not any such person shall have become a party to this Agreement and have agreed in writing to join herein and be bound by the terms hereof. 

  
 -5-

 IN WITNESS WHEREOF, the parties have executed this Agreement on the
day and year first indicated above. 
  

			
	WHITEGLOVE HEALTH, INC.
		
	By:	 	 
	Title:	 	 
	Address:	 	 
	     

 

			
	PARTICIPANT
	
	 
	Print Name:	 	 
	Address:	 	 
	    

  
 -6-

 SPOUSAL ACKNOWLEDGMENT 

The undersigned spouse of Participant has read and hereby approves the foregoing Stock Issuance Agreement. In
consideration of the Company’s granting Participant the right to acquire the Restricted Shares in accordance with the terms of such Agreement, the undersigned hereby agrees to be irrevocably bound by all the terms of such Agreement, including
(without limitation) the right of the Company (or its assigns) to purchase any Restricted Shares in which Participant is not vested at the time of his or her cessation of service. 

 

			
	
	 
	PARTICIPANT’S SPOUSE
		
	Address:	 	 
	    

 EXHIBIT I 
 ASSIGNMENT SEPARATE FROM CERTIFICATE 
 FOR VALUE
RECEIVED                      hereby sell(s), assign(s) and transfer(s) unto WhiteGlove Health, Inc. (the
“Company”),                      (            )
shares of the Common Stock of the Company standing in his or her name on the books of the Company represented by Certificate No.
                     herewith and do(es) hereby irrevocably constitute and appoint
                     Attorney to transfer the said stock on the books of the Company with full power of substitution in the premises.

  

									
	Dated: 	 	 	 		 	Signature 	 	 

 Instruction: Please do not
fill in any blanks other than the signature line. Please sign exactly as you would like your name to appear on the issued stock certificate. The purpose of this assignment is to enable the Company to exercise the Repurchase Right without requiring
additional signatures on the part of Participant. 
 Exhibit I to Stock Issuance Agreement 

 EXHIBIT II 
 SECTION 83(B) TAX ELECTION 

 SECTION 83(B) ELECTION 

This statement is being made under Section 83(b) of the Internal Revenue Code, pursuant to Treas. Reg.
Section 1.83-2. 
  

	(1)	 The taxpayer who performed the services is: 

Name:
                                         
                                        
                    
 Address:
                                         
                                         
               
 Taxpayer Ident. No.:
                                         
                                    

 

	(2)	 The property with respect to which the election is being made is
                     shares of the Common Stock of WhiteGlove Health, Inc. 

 

	(3)	 The property was issued on
                    ,             . 

 

	(4)	 The taxable year in which the election is being made is the calendar year
            . 

  

	(5)	 The property is subject to a repurchase right pursuant to which the issuer has the right to acquire the property at the lower of the purchase price
paid per share or the fair market value per share, if for any reason taxpayer’s service with the issuer terminates. The issuer’s repurchase right will lapse in a series of annual installments over a four (4)-year period ending on
                    , 20        . 

 

	(6)	 The fair market value at the time of transfer (determined without regard to any restriction other than a restriction which by its terms will never
lapse) is $                     per share. 

  

	(7)	 The amount paid for such property is
$                     per share. 

  

	(8)	 A copy of this statement was furnished to WhiteGlove Health, Inc. for whom taxpayer rendered the services underlying the transfer of property.

  

	(9)	 This statement is executed on
                    , 20        . 

 

					
	  	 		 	  
	Spouse (if any)	 		 	Taxpayer

 This election must be filed
with the Internal Revenue Service Center with which taxpayer files his or her Federal income tax returns and must be made within thirty (30) days after the execution date of the Stock Issuance Agreement. This filing should be made by registered
or certified mail, return receipt requested. Participant must retain two (2) copies of the completed form for filing with his or her Federal and state tax returns for the current tax year and an additional copy for his or her records.

 Exhibit II to Stock Issuance AgreementEmploynent Agreement - Robert A. Fabbio

 Exhibit 10.14 
 EMPLOYMENT AGREEMENT 
 THIS EMPLOYMENT AGREEMENT (the
“Agreement”) is entered into as of April 26, 2007, by and between WHlTEGLOVE HOUSE CALL HEALTH, Inc., a Texas corporation (the “Company”), and Robert A. Fabbio, an individual (the
“Executive”). 
 RECITALS 

WHEREAS, Executive is to be employed by the Company as the President and Chief Executive Officer effective April 26, 2007 (the
“Employment Commencement Date”); 
 WHEREAS, the Company desires to continue to employ Executive as the
President and Chief Executive Officer of the Company and Executive desires to continue employment with the Company in accordance with the contractual terms and conditions set forth below; and 

WHEREAS, this Agreement is intended to, and shall, set forth the definitive agreement of the parties regarding the subject matter hereof.

 AGREEMENT 
 NOW, THEREFORE, for and in consideration of these recitals and premises, and the respective promises,covenants and agreements contained herein, and intending to be legally bound hereby, the parties
hereto agree as follows: 
 Section 1. Employment. The Company hereby agrees to continue to employ Executive, and
Executive hereby accepts such continued employment with the Company upon the terms and conditions hereafter set forth. 

Section 2. Position. Executive shall serve as President and Chief Executive Officer and shall report directly to the Board of
Directors of the Company or such person(s) as the Board of Directors may designate from time to time (the “Service”). 
 Section 3. At-will Employment. Executive’s employment with the Company is “at-will” which means that the employment with Company is for no specific period or time and may be
modified or terminated by Company or Executive at any time and for any reason, with or without prior notice and with or without cause. The at-will nature of the employment may only be altered by a written agreement approved and executed by the Board
of Directors of the Company. 
 Section 4. Duties of Executive. Executive shall have the authority and perform such
executive duties as a President and Chief Executive Officer would normally perform or as otherwise specified in the By-Laws of the Company as in effect on the date of this Agreement, which may change from time to time, and shall perform in addition
thereto, such other duties as the Board of Directors of the Company (together with any applicable sub-committee or sub-committees thereof, the “Board”) may request, consistent with Executive’s office and title. Executive shall devote
all of his working time and his best efforts to the performance of his duties under this Agreement and the furtherance of the interests of the Company, except as may otherwise be approved in advance by the Board. Notwithstanding the foregoing,
nothing contained herein shall preclude Executive from having outside commitments (including as a member of the Board of Directors of other companies). 

  

			
	EMPLOYMENT AGREEMENT	 	PAGE 1

 Section 5. Compensation; Benefits). 

(a) Base Salary. Commencing August 15, 2008, Executive’s base salary, less applicable statutory deductions and
withholdings, is $180,000 on an annualized basis (“Base Salary”). The Base Salary shall be payable at the times and in the manner consistent with the Company’s general policies regarding compensation of executive
employees, but in no event less frequently than once each calendar month unless otherwise provided under applicable law. 
 (b)
Bonus. Commencing August 15, 2008, Executive shall be eligible to receive additional compensation in the form of a quarterly bonus of up to $6,250, less applicable statutory deductions and withholdings (the “Additional
Bonus”). The Additional Bonus may be granted to him by the Board based on the attainment of 100% of certain quarterly objectives that are to be set by the Compensation Committee of the Board at the beginning of each quarter, in its sole
discretion, with input from Executive. Such Bonus shall be payable during the quarter following the quarter in which it is earned and may be prorated, at Company’s discretion, if objectives arc partially met. 

(c) Vacation, Sick Leave and Holidays. Executive shall be entitled to paid vacation benefits, sick leave, and holidays in accordance
with applicable Company policies, as presently in effect and amended from time to time. 
 (d) Benefits. Executive
shall be eligible for and entitled to participate in all other benefit plans and arrangements as may he maintained by the Company for its executive officers in accordance with applicable Company policies and the terms of the applicable benefit plans
as presently in effect and amended from time to time, such as, without limitation, any medical, dental, vision, pension, 401(k), and accident, disability, and life insurance benefits. 

Section 6. Termination Payment. 
 (a) If Executive’s employment hereunder is terminated by the Company other than for Cause (as defined in Section 6(b) below) the Company shall be obligated to pay to Executive a lump sum in an
amount equal to nine months of the then Base Salary, less applicable statutory withholding and deductions, provided that the Company’s obligation to pay and Executive’s right to receive such pay shall be conditioned upon Executive’s
execution of a general release and covenant not to sue the Company and related parties in a form acceptable to the Company (the “General Release”). Such payment shall be made 14 days after the effective date of the General
Release, as defined in the General Release. 
 (b) “Cause” for purposes of termination of
Executive’s employment shall mean gross negligence, willful misconduct, fraud, embezzlement and/or unauthorized use of corporate funds. 
 Section 7. Entire Agreement. This Agreement, together with the Confidential Proprietary Information and Invention Assignment Agreement attached as Exhibit A, any indemnity agreement
between Executive and the Company, and option (or restricted stock) agreements now or hereafter entered into, constitute the entire agreement between the Company and Executive regarding Executive’s employment by the Company. 

  

			
	EMPLOYMENT AGREEMENT	 	PAGE 2

 Section 8. Governing Law; Venue. The validity, interpretation, construction and
performance or this Agreement will be governed by and construed in accordance with the substantive laws of the State or Texas, without giving effect to the principles of conflict of laws of such State. WITH RESPECT TO ANY SUIT, ACTION OR OTHER
PROCEEDING ARISING FROM (OR RELATING TO) THIS AGREEMENT, THE COMPANY AND EXECUTIVE HEREBY IRREVOCABLY AGREE TO THE EXCLUSIVE PERSONAL JURISDICTION AND VENUE OF THE UNITED STATES DISTRICT COURT IN TEXAS AND IN ANY STATE COURT WITHIN TRAVIS COUNTY,
TEXAS. 
 Section 9. Severability and Reformation. If any provision of this Agreement is held to be illegal, invalid
or unenforceable under any present or future law, and if the rights or obligations of the parties under this Agreement would not be materially and adversely affected thereby, such provision shall be fully separable, and this Agreement shall be
construed and enforced as if such illegal, invalid or unenforceable provision had never comprised a part thereof, the remaining provisions of this Agreement shall remain in full force and effect and shall not be affected by the illegal, invalid or
unenforceable provision or by its severance therefrom, and, in lieu of such illegal, invalid or unenforceable provision, there shall be added automatically as a part of this Agreement a legal, valid and enforceable provision as similar in terms to
such illegal, invalid or unenforceable provision as may be possible and the parties hereto request the court or any arbitrator to whom disputes relating to this Agreement are submitted to reform the otherwise illegal, invalid or unenforceable
provision in accordance with this Section 9. 
 Section 10. Miscellaneous. No provision of this Agreement may
be modified, waived or discharged unless such waiver, modification or discharge is agreed to in writing signed by Executive and Board of Directors of the Company. No waiver by either party hereto at any time of any breach by the other party hereto
or compliance with any condition or provision of this Agreement to be performed by such other party will be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time. Unless otherwise noted,
references to “Sections” are to sections of this Agreement. The captions used in this Agreement arc designed for convenient reference only and are not to be used for the purpose of interpreting any provision of this
Agreement. 
 Section 11. Counterparts. This Agreement may be executed in one or more counterparts, each of which
shall be deemed to be an original but all of which together will constitute one and the same Agreement. The delivery by facsimile of an executed counterpart of this Agreement shall be deemed to be an original and shall have the full force and effect
of an original copy. 
 [Signature page follows] 

  

			
	EMPLOYMENT AGREEMENT	 	PAGE 3

 IN WITNESS WHEREOF, the parties hereof have executed this Amendment to Employment
Offer Letter as of the day and year first-above written. 
  

			
	“EXECUTIVE”
		
	By:	 	  

		 	Robert A. Fabbio
	
	  

	Address
	
	  

	Address
	
	“COMPANY”
	
	WHITEGLOVE HOUSE CALL HEALTH, INC.
		
	By:	 	  

	Name:	 	  

	Title:	 	  

  

			
	EMPLOYMENT AGREEMENT	 	PAGE 4

 EXHIBIT A 
 Confidential Information and Invention Assignment Agreement 

  

			
	PROPRIETARY INFORMATION AGREEMENT	 	PAGE 1

 Confidential Information and Invention Assignment Agreement 

In consideration of my employment or continued employment by WHITEGLOVE HOUSE CALL HEALTH, INC. or by a subsidiary of WHITEGLOVE HOUSE CALL HEALTH, INC.
(WHITEGLOVE HOUSE CALL HEALTH, INC. and its subsidiaries are referred to separately or together as “WHlTEGLOVE”), WHITEGLOVE’S disclosure of certain Confidential or Proprietary Information (as defined below) to me, any compensation
now and/or hereafter paid to me, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged. I agree to honor and to be bound by the provisions of this Confidential Information and Invention Assignment
Agreement (the “Agreement”). 
 1. I will devote my best effort to performing well all duties that WHITEGLOVE may assign to me from
time to time. 
 2. While I am a WHITEGLOVE employee, I will promptly disclose each discovery, idea, improvement or invention I create,
conceive, develop or discover, alone or with others, which relates to WHITEGLOVE’s business or results from the use of WHITEGLOVE’s equipment, supplies, facilities or information (“Intellectual Property”). All Intellectual
Property, in whatever form, is WHITEGLOVE’s property. I assign to WHITEGLOVE, without additional compensation, all of my rights, title and interest in all Intellectual Property. I will assist WHITEGLOVE in all ways in the future, including
giving evidence and executing any documents deemed helpful or necessary by WHITEGLOVE, to establish, perfect and register worldwide; at WHITEGLOVE’s expense, WHITEGLOVE’s title and exclusive ownership in Intellectual Property. I will not
do anything in conflict with WHITEGLOVE’s rights in Intellectual Property and will cooperate fully to protect Intellectual Property against misappropriation or infringement. 
 3. I agree that WHITEGLOVE will be the copyright owner in all copyrightable works of every kind and description created or developed by me, solely or jointly with others, within the scope of my employment
or which relates to WHITEGLOVE’s business, results from copyrightable works owned by WHITEGLOVE (i.e. derivative works), or results from or involves any information obtained in connection with my employment with WHITEGLOVE. I hereby assign to
WHITEGLOVE all my right, title and interest in any such works. If requested to, and at no further expense to WHITEGLOVE, I will execute in writing any acknowledgement or assignments of copyright ownership of such works as may be appropriate for
preservation of the worldwide ownership in WHITEGLOVE of such copyrights. 
 4. I will not use, publish, misappropriate or disclose any
Confidential or Proprietary Information, during or after my employment, except as required in the performance of my duties for WHITEGLOVE or as authorized in writing by WHITEGLOVE. Confidential and Proprietary information includes information I
learn or originate during my employment which is not publicly available or readily ascertainable by proper means, and includes such information disclosed by others in confidence to WHITEGLOVE. If I have doubts concerning whether particular
information is Proprietary, I will promptly consult my supervisor or legal counsel as WHITEGLOVE may direct for guidance in advance. Confidential and Proprietary Information includes, but is not necessarily limited to, the information described in
subparagraphs A through D below. 
 A. Manufacturing and research processes currently in use, planned or under development,
including design rules, device characteristics, process flows, manufacturing capabilities and yields, and product, process and device strategies planned or under development, including device specific action, systems architectures logic designs,
circuit implementation and long-range plans. 

 B. Software products in use, planned or under development, including operating system
adaptations or enhancements, language compilers, interpreters and translators, system design and evaluation tools and application programs. 
 C. Information relating to WHITEGLOVE employees, including corporate structure; actual and anticipated relationships between WHITEGLOVE and other companies, sales levels, profit levels, pricing and other
unpublished financial date; and budget, staffing, compensation, equipment and related plans. 
 D. Information relating to
WHITEGLOVE’s customer, prospects and vendor relationships. This includes performance requirements, development and delivery schedules, device and product pricing and quantities, and other information communicated to WHITEGLOVE by customers or
vendors. 
 E. Business strategies in use or planned. 
 F. Information related to WHITEGLOVE’s financial condition, including financial statements and capitalization. 
 5. I will not use in my work or disclose to WHITEGLOVE any Confidential or Proprietary Information of a third party unless WHITEGLOVE first receives written authorization from the third party allowing the
use or disclosure of such information and unless WHITEGLOVE agrees in writing to receive such information on terms acceptable to WHITEGLOVE. I will abide by restrictions imposed on the disclosure and use of such third party information. I further
agree that my name, voice, picture and likeness may be used in WHITEGLOVE’s advertising, training aides and other materials without payment of separate compensation to me. 
 6. During my employment, I will not, directly or indirectly, participate in the ownership, management, operation, financing or control of, or be employed by or consult for or otherwise render services to,
any person, corporation, firm, or other entity that competes with the WHITEGLOVE in the state or Texas, or in any other state in the United States, or in any country in the world, in the conduct of the business of the WHITEGLOVE as conducted or as
proposed to be conducted. 
 During my employment and for a period of one (1) year after my employment is terminated for
any reason, I will not, directly or indirectly, individually or on behalf or any other person, firm, partnership, corporation, or business entity of any type, solicit, assist or in any way encourage any current employee or consultant of the
WHITEGLOVE to terminate his or her employment relationship or consulting relationship with or for the WHITEGLOVE, nor will I solicit the services of any former employee of the WHITEGLOVE whose service has been terminated for less than three
(3) months. 

 For a period of one (1) year after my employment is terminated for any reason, I will
not, directly or indirectly, individually or on behalf of any other person, firm, partnership, corporation, or business entity of any type, solicit to the detriment of the WHITEGLOVE and/or for the benefit of any competitor of the WHITEGLOVE, take
away or attempt to take away, in whole or in part, any Customer of the WHITEGLOVE or otherwise interfere with the WHITEGLOVE’s relationship with any Customer. For purposes of this Section 6, “Customer” shall
mean any WHITEGLOVE or business entity to which the WHITEGLOVE sells or licenses goods or services to or that I had contact with or performed services for during my employment. 
 7. I hereby agree that for a period of three months after the date my employment is terminated, for any reason, I will not, directly or indirectly, in the state of Texas, or in. any other State of the
United States, or in any country in the world where the WHITEGLOVE engages or proposes to engage in Business, as of the date of the termination of my employment, (i) compete with the WHITEGLOVE in Business or (ii) participate in the
ownership, management, operation, financing, or control of, or be employed by or consult for or otherwise render services to, any person, corporation, firm, or other entity that competes with the WHITEGLOVE in Business. Notwithstanding the
foregoing, I am permitted to own up to 5% of any class of securities of any corporation in competition with the WHITEGLOVE that is traded on a national securities exchange or through NASDAQ. For the purposes of this Section 7,
“Business” shall mean those portions of’ the WHITEGLOVE’s business in which I actively participated or received Proprietary Information regarding. 
 8. When my employment with WHITEGLOVE ends, I will promptly deliver to a designated WHITEGLOVE representative all originals and copies of all materials·, documents and property of WHITEGLOVE which
are in my possession or control. I also will cooperate in an exit interview whose purpose will be to review Confidential and Proprietary Information known or possessed by me and to confirm WHITEGLOVE’s rights regarding the protection of the
Confidential Proprietary Information and the disclosure to WHITEGLOVE and its ownership of Intellectual Property. 
 9. This Agreement will be
governed by and construed according to the laws of the State of Texas without regard to conflicts of law principles. 
 10. I acknowledge and
agree that each agreement and covenant set forth herein constitutes a separate agreement independently supported by good and adequate consideration and that each such agreement shall be severable from the other provisions of this Agreement and shall
survive this Agreement. 
 I understand and agree that Section 7 of this Agreement is to be enforced to the fullest
extent permitted by law. Accordingly, if a court of competent jurisdiction determines that the scope and/or operation of Section 7 is too broad to be enforced as written, the WHITEGLOVE and I intend that the court should reform such
provision to such narrower scope and/or operation as it determines to be enforceable, provided, however; that such reformation applies only with respect to the operation of such provision in the particular jurisdiction with respect to which such
determination was made. If, however, Section 7 is held to be illegal, invalid, or unenforceable under present or future law, and not subject to reformation, then (i) such provision shall be fully severable, (ii) this Agreement
shall be construed and enforced as if such provision was never a 

 
part of this Agreement, and (iii) the remaining provisions of’ this Agreement shall remain in full force and effect and shall not be affected by the illegal, invalid, or unenforceable
provision or by its severance. 
 11. This Agreement will be binding upon my heirs, executors, administrators, and other legal representatives
and will be for the benefit of the WHITEGLOVE, its successors and assigns. I expressly agree that the WHITEGLOVE has the right to assign this Agreement. 
 12. The provisions of this Agreement shall survive the termination of my employment for any reason and the assignment of this Agreement by the WHITEGLOVE to any successor in interest or other assignee.

 13. No waiver by the WHITEGLOVE of any breach of this Agreement shall be a waiver of any preceding or succeeding breach. No waiver by the
WHITEGLOVE of any right under this Agreement shall be construed as a waiver of any other right. The WHITEGLOVE shall not be required to give notice to enforce strict adherence to all terms of this Agreement. 

14. In the event of any litigation arising from or relating to this Agreement, the prevailing party in such litigation proceedings shall be entitled to
recover, from the non-prevailing party, the prevailing party’s costs and reasonable attorney’s fees, in addition to all other legal or equitable remedies to which it may otherwise be entitled. 

I have carefully read this Agreement; I understand and accept its terms. I agree that I will continue to be bound by the provisions of
this Agreement after my employment with WHITEGLOVE has ended. 
  

			
	I accept the terms of this Agreement
		
	Signed:	 	  

		
	Date:	 	  

 AMENDMENT 1 TO EMPLOYMENT AGREEMENT 

THIS AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (the “Amendment”) is entered into as of the 26th day of
April, 2011 (the “Effective Date”), by and between WhiteGlove House Call Health, Inc., a Delaware corporation (the “Company”), and Robert A. Fabbio, an individual (the
“Executive”). 
 Recitals: 

WHEREAS, the parties have previously entered into an Employment Agreement dated April 26, 2007 (the “Employment
Agreement”), 
 WHEREAS, members of the Compensation Committee of the Board of Directors of the Company
previously approved an increase to the Executive’s Base Salary (as defined in the Employment Agreement) and Additional Bonus (as defined in the Employment Agreement), but such changes were not reflected in an amendment to the Employment
Agreement; and 
 WHEREAS, the parties wish to amend the Employment Agreement by entering into this Amendment where the
terms and conditions of such Employment Agreement remain in full force and effect and are only modified to the extent of this Amendment; 
 NOW THEREFORE, in consideration of the parties’ continuing obligations, the parties agree to revise the Employment Agreement as follows and that the provisions of the Employment Agreement that
are not revised in this Amendment shall continue in full force and effect as stated in the Employment Agreement; 
 Section 12.
Amendment to Section 5(a) and Section 5(b). Section 5(a) and Section 5(b) of the Employment Agreement are hereby amended and restated in their entirety to read as follows: 

(a) Base Salary. Commencing March 16, 2011, Executive’s base salary, less applicable statutory deductions and
withholdings is $340,000 on an annualized basis (“Base Salary”). The Base Salary shall be payable at the times and in the manner consistent with the Company’s general policies regarding compensation of executive
employees, but in no event less frequently than once each calendar month unless otherwise provided under applicable law. 
 (b)
Bonus. Commencing March 16, 2011, Executive shall be eligible to receive additional compensation in the form of a quarterly bonus of up to $50,000, less applicable statutory deductions and withholdings (the “Additional
Bonus”). The Additional Bonus may be granted to him by the Board based on the attainment of 100% of certain quarterly objectives that are to be set by the Compensation Committee of the Board at the beginning of each quarter, in its sole
discretion, with input from Executive. Such Bonus shall be payable during the quarter following the quarter in which it is earned and may be prorated, at Company’s discretion, if objectives are partially met. 

 Section 13. Miscellaneous. 

(a) Waivers and Amendments. With the written consent of the Company and the Executive, the obligations of the Company and the
rights of the Executive under this Amendment may be waived (either generally or in a particular instance, either retroactively or prospectively and either for a specified period of time or indefinitely), and with the same consent of the Company and
the Executive, the Company may enter into a supplementary agreement for the purpose of adding any provisions to or changing in any manner or eliminating any of the provisions of this Amendment. 

(b) Governing Law. THIS AMENDMENT SHALL BE GOVERNED IN ALL RESPECTS BY THE LAWS OF THE STATE OF TEXAS AS SUCH LAWS ARE APPLIED TO
AGREEMENTS BETWEEN TEXAS RESIDENTS ENTERED INTO AND TO BE PERFORMED ENTIRELY WITHIN THE STATE OF TEXAS, WITHOUT REGARD TO CONFLICT OF LAWS RULES. 
 (c) Successors and Assigns. The provisions hereof shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors and administrators of the parties hereto. 

(d) Entire Agreement. This Amendment constitutes the full and entire understanding and agreement between the parties with regard
to the subjects hereof. 
 (e) Notices. All notices and other communications required or permitted hereunder shall be
given in accordance with the Employment Agreement. 
 (f) Counterparts. This Agreement may be executed in any number of
counterparts, each of which shall be an original, but all of which together shall be deemed to constitute one instrument. 
 (g)
Telecopy Execution and Delivery. A facsimile, telecopy or other reproduction of this Amendment may be executed by one or more parties hereto, and an executed copy of this Amendment may be delivered by one or more parties hereto by facsimile
or similar electronic transmission device pursuant to which the signature of or on behalf of such party can be seen, and such execution and delivery shall be considered valid, binding and effective for all purposes. At the request of any party
hereto, all parties hereto agree to execute an original of this Amendment as well as any facsimile, telecopy or other reproduction hereof. 

 IN WITNESS WHEREOF, the parties hereto have caused this instrument to be executed by
themselves or their duly authorized offers as of the day, month and year first above written. 
  

											
	“EXECUTIVE”	 	 	 	 	 	“COMPANY”
					
		 		 		 		 	WHITEGLOVE HOUSE CALL HEALTH, INC.
						
	By:	 	  
	 		 		 	By:	 	  

		 	 Robert A. Fabbio
	 		 		 		 	
						
	Address:	 	  
	 		 		 	Name:	 	  

						
	Address:	 	  
	 		 		 	Title:	 	  

 WHITEGLOVE HOUSE CALL HEALTH, INC. 
 AMENDMENT NO 1 TO EMPLOYMENT AGREEMENT 
 SIGNATURE PAGE

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00190-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00190-of-00352.parquet"}]]